Etiologies and Patterns of Valvular Heart Disease Among Cardiac Patients at the Cardiac Center of Ethiopia During February 2000 to April 2022

References

• Aluru JS, Barsouk A, Saginala K, Rawla P, Barsouk A. Valvular heart disease epidemiology. Med Sci. 2022;10(2):32.
   Google Scholar
• Zeng Y, Sun R, Li X, Liu M, Chen S, Zhang P. Pathophysiology of valvular heart disease (Review). Exp Ther Med. 2016;11(4):1184–1188. doi:10.3892/etm.2016.3048
   PubMed Web of Science ®Google Scholar
• Topilsky Y. Tricuspid valve regurgitation: epidemiology and pathophysiology. Minerva Cardioangiol. 2018;66(6):673–679. doi:10.23736/S0026-4725.18.04670-4
   PubMed Web of Science ®Google Scholar
• Hollenberg SM. Valvular heart disease in adults: etiologies, classification, and diagnosis. FP Essent. 2017;457:11–16.
   PubMedGoogle Scholar
• Coffey S, Roberts-Thomson R, Brown A, et al. Global epidemiology of valvular heart disease. Nat Rev Cardiol. 2021;18(12):853–864. doi:10.1038/s41569-021-00570-z
   PubMed Web of Science ®Google Scholar
• Coffey S, Cairns BJ, Iung B. The modern epidemiology of heart valve disease. Heart. 2016;102(1):75–85. doi:10.1136/heartjnl-2014-307020
   PubMed Web of Science ®Google Scholar
• Huntley GD, Thaden JJ, Nkomo VT. Chapter 3 - Epidemiology of heart valve disease. In: Kheradvar A, editor. Principles of Heart Valve Engineering [Internet]. Academic Press; 2019:41–62. Available from: https://www.sciencedirect.com/science/article/pii/B9780128146613000034. Accessed June 26, 2023.
   Google Scholar
• Iung B, Vahanian A. Epidemiology of valvular heart disease in the adult. Nat Rev Cardiol. 2011;8(3):162–172. doi:10.1038/nrcardio.2010.202
   PubMed Web of Science ®Google Scholar
• Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368(9540):1005–1011. doi:10.1016/S0140-6736(06)69208-8
   PubMed Web of Science ®Google Scholar
• Yang Y, Wang Z, Chen Z, et al. Current status and etiology of valvular heart disease in China: a population-based survey. BMC Cardiovasc Disord. 2021;21(1):339. doi:10.1186/s12872-021-02154-8
   PubMed Web of Science ®Google Scholar
• Nkomo VT. Epidemiology of valvular heart diseases in Africa: valvular heart disease. SA Heart. 2009;Jun(1):12–18.
   Google Scholar
• Chen J, Li W, Xiang M. Burden of valvular heart disease, 1990–2017: results from the Global Burden of Disease Study 2017. J Glob Health. 2023;10(2):020404. doi:10.7189/jogh.10.020404
   Google Scholar
• Iung B, Delgado V, Rosenhek R, et al. Contemporary presentation and management of valvular heart disease. Circulation. 2019;140(14):1156–1169. doi:10.1161/CIRCULATIONAHA.119.041080
   PubMed Web of Science ®Google Scholar
• Cupido BJ, Ntusi NB, Peters F. An approach to the diagnosis and management of valvular heart disease: article. S Afr Med J. 2016;106(1):39–42. doi:10.7196/SAMJ.2016.v106i1.10326
   PubMed Web of Science ®Google Scholar
• Domenech B, Pomar JL, Prat-González S, et al. Valvular heart disease epidemics. J Heart Valve Dis. 2016;25(1):1–7.
   PubMedGoogle Scholar
• Abdissa SG, Oli K, Feleke Y, Goshu DY, Begna DM, Tafese A. Spectrum of cardiovascular diseases among Ethiopian patients at Tikur Anbessa Specialized University Teaching Hospital, Addis Ababa. Ethiop Med J. 2014;52(1):9–17. PMID: 25069209.
   PubMedGoogle Scholar
• Guteta S, Yadeta D, Azazh A, Mekonnen D. Cardiac surgery for valvular heart disease at a referral hospital in Ethiopia: a review of cases operated in the last 30 years. Ethiop Med J. 2016;54(2):49–55.
   PubMedGoogle Scholar
• Gemechu T, Mahmoud H, Parry EH, Phillips DI, Yacoub MH. Community-based prevalence study of rheumatic heart disease in rural Ethiopia. Eur J Prev Cardiol. 2017;24(7):717–723. doi:10.1177/2047487316687104
   PubMed Web of Science ®Google Scholar
• Yadeta D, Hailu A, Haileamlak A, et al. Prevalence of rheumatic heart disease among school children in Ethiopia: a multisite echocardiography-based screening. Int J Cardiol. 2016;221:260–263. doi:10.1016/j.ijcard.2016.06.232
   PubMed Web of Science ®Google Scholar
• Alıcı G, Genç Ö. Spectrum of cardiovascular diseases at a referral tertiary care hospital in Somalia, Mogadishu: an echocardiographic study. BMC Cardiovasc Disord. 2021;21(1):599. doi:10.1186/s12872-021-02417-4
   PubMed Web of Science ®Google Scholar
• Kazahura PT, Mushi TL, Pallangyo P, et al. Prevalence and risk factors for Subclinical Rheumatic Heart Disease among primary school children in Dar es Salaam, Tanzania: a community based cross-sectional study. BMC Cardiovasc Disord. 2021;21(1):610. doi:10.1186/s12872-021-02377-9
   PubMed Web of Science ®Google Scholar
• Adem A, Abebe S, Hailu A, et al. Heart diseases in North Ethiopia pattern of echocardiographic abnormalities among adult cardiac patients - an experience from Ayder Hospital of Mekelle University. Ethiop Med J. 2014;52(4):173–183.
   PubMedGoogle Scholar
• Manjunath CN, Srinivas P, Ravindranath KS, Dhanalakshmi C. Incidence and patterns of valvular heart disease in a tertiary care high-volume cardiac center: a single center experience. Indian Heart J. 2014;66(3):320. doi:10.1016/j.ihj.2014.03.010
   PubMedGoogle Scholar
• Huang X, Dhruva SS, Yuan X, et al. Characteristics, interventions and outcomes of patients with valvular heart disease hospitalised in China: a cross-sectional study. BMJ Open. 2021;11(11):e052946. doi:10.1136/bmjopen-2021-052946
   PubMed Web of Science ®Google Scholar
• Choi YJ, Son JW, Kim EK, et al. Epidemiologic profile of patients with valvular heart disease in Korea: a nationwide hospital-based registry study. J Cardiovasc Imaging. 2023;31(1):51–61. doi:10.4250/jcvi.2022.0076
   PubMedGoogle Scholar
• Andell P, Li X, Martinsson A, et al. Epidemiology of valvular heart disease in a Swedish nationwide hospital-based register study. Heart. 2017;103(21):1696–1703. doi:10.1136/heartjnl-2016-310894
   PubMed Web of Science ®Google Scholar
• Mulugeta T, Kumela K, Chelkeba L. Clinical, echocardiographic characteristics and management practices in patients with rheumatic valvular heart disease. Open Access Rheumatol Res Rev. 2020;12:233–239.
   PubMed Web of Science ®Google Scholar
• Desta TT, Gezachew A, Eshetu K. Descriptive analysis of rheumatic heart disease related complications in pediatric patients at Tertiary Hospital, Addis Ababa, Ethiopia. Pediatr Health Med Ther. 2023;14:45–57. doi:10.2147/PHMT.S396854
   PubMed Web of Science ®Google Scholar
• Lubega S, Aliku T, Lwabi P. Echocardiographic pattern and severity of valve dysfunction in children with rheumatic heart disease seen at Uganda Heart Institute, Mulago hospital. Afr Health Sci. 2014;14(3):617–625. doi:10.4314/ahs.v14i3.17
   PubMed Web of Science ®Google Scholar
• Zühlke L, Engel ME, Karthikeyan G, et al. Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: the Global Rheumatic Heart Disease Registry (the REMEDY study). Eur Heart J. 2015;36(18):1115–1122. doi:10.1093/eurheartj/ehu449
   PubMed Web of Science ®Google Scholar
• Marciniak A, Glover K, Sharma R. Cohort profile: prevalence of valvular heart disease in community patients with suspected heart failure in UK. BMJ Open. 2017;7(1):e012240. doi:10.1136/bmjopen-2016-012240
   PubMed Web of Science ®Google Scholar
• Demirbağ R, Sade LE, Aydın M, Bozkurt A, Acartürk E. The Turkish registry of heart valve disease. Turk Kardiyol Dern Ars. 2013;41(1):1–10. PMID: 23518931. doi:10.5543/tkda.2013.71430
   PubMedGoogle Scholar
• Ribeiro GS, Tartof SY, Oliveira DWS, et al. Surgery for valvular heart disease: a population-based study in a Brazilian Urban Center. PLoS One. 2012;7(5):e37855. doi:10.1371/journal.pone.0037855
   PubMed Web of Science ®Google Scholar
• Aikawa E, Schoen FJ. Chapter 9 - Calcific and Degenerative Heart Valve Disease. In: Willis MS, Homeister JW, Stone JR, editors. Cellular and Molecular Pathobiology of Cardiovascular Disease [Internet]. San Diego: Academic Press; 2014: 161–180. Available from: https://www.sciencedirect.com/science/article/pii/B9780124052062000090. Accessed June 26, 2023.
   Google Scholar
• Adem A, Dukessa Gemechu T, Jarso H, et al. Rheumatic heart disease patients’ adherence to secondary prophylaxis and associated factors at Hospitals in Jimma Zone, Southwest Ethiopia: a multicenter study. Patient Prefer Adher. 2020;14:2399–2406. doi:10.2147/ppa.s281413
   PubMed Web of Science ®Google Scholar
• Adal AB, Fetensa G, Chamiso TM, et al. Adherence to secondary prophylaxis and risk factors among patients with rheumatic heart disease at public hospitals in Addis Ababa, Ethiopia, 2021–2022. Res Rep Clin Cardiol. 2022;13:73–84. doi:10.2147/rrcc.s373939
   Web of Science ®Google Scholar
• Shafi MJ, Nasrin S. Incidence & pattern of valvular heart disease in patients attended in Echo Lab at a tertiary care hospital: a single centre study. Cardiovasc J. 2021;13(2):144–153. doi:10.3329/cardio.v13i2.52968
   Google Scholar
• Alpízar-Rodríguez D, Pluchino N, Canny G, Gabay C, Finckh A. The role of female hormonal factors in the development of rheumatoid arthritis. Rheumatology. 2017;56(8):1254–1263. doi:10.1093/rheumatology/kex239
   PubMed Web of Science ®Google Scholar